Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation
Chuan Qin,1,* Yongning Li,2,* Kewei Wang1 1Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & Comparative Medical Center, Peking Union Medical College, Beijing, 100021, People’s Republic of China; 2Department of International Medical Service & Depa...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/5fb525e1262441c984af6b4faf1ed856 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:5fb525e1262441c984af6b4faf1ed856 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:5fb525e1262441c984af6b4faf1ed8562021-12-02T18:49:48ZFunctional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation1178-7031https://doaj.org/article/5fb525e1262441c984af6b4faf1ed8562021-09-01T00:00:00Zhttps://www.dovepress.com/functional-mechanism-of-bone-marrow-derived-mesenchymal-stem-cells-in--peer-reviewed-fulltext-article-JIRhttps://doaj.org/toc/1178-7031Chuan Qin,1,* Yongning Li,2,* Kewei Wang1 1Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & Comparative Medical Center, Peking Union Medical College, Beijing, 100021, People’s Republic of China; 2Department of International Medical Service & Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People’s Republic of China*These authors contributed equally to this workCorrespondence: Kewei Wang 5 Panjiayuan Nanli St., Beijing, 100021, People’s Republic of ChinaTel +010-67779915Email kkww02052015@hotmail.comAbstract: The transplantation of bone marrow-derived mesenchymal stem cells (BMMSCs) alleviates neuropathology and improves cognitive deficits in animal models with Alzheimer’s disease. However, the underlying mechanisms remain to be determined. Available data demonstrate transplanted BMMSCs can inhibit neuroinflammation, which may be related to microglial M1/M2 polarization and is regulated by the secretion of autocrine and paracrine cytokines. BMMSCs also mitigate Aβ plaques and Tau tangles in the brain, which may be associated with the recruitment of peripheral blood monocytes and the subsequent comprehensive effects. The therapeutic effects of stem cells involve potential mechanisms such as immunomodulation, apoptosis, and proliferation. BMMSC-mediated functional reconstruction through dynamic remodeling develops a novel balance. Herein, present review recapitulates the molecular basis of BMMSC-assisted biological processes and summarizes the possible mechanisms related to the interaction between BMMSCs and microglia. The transplanted BMMSCs can suppress neuroinflammation that plays a key role in the pathogenesis of Alzheimer’s disease.Keywords: Alzheimer’s disease, bone marrow-derived mesenchymal stem cells, microglia, immunomodulation, apoptosisQin CLi YWang KDove Medical Pressarticlealzheimer’s diseasebone marrow-derived mesenchymal stem cellsmicrogliaimmunomodulationapoptosisPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 4761-4775 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
alzheimer’s disease bone marrow-derived mesenchymal stem cells microglia immunomodulation apoptosis Pathology RB1-214 Therapeutics. Pharmacology RM1-950 |
| spellingShingle |
alzheimer’s disease bone marrow-derived mesenchymal stem cells microglia immunomodulation apoptosis Pathology RB1-214 Therapeutics. Pharmacology RM1-950 Qin C Li Y Wang K Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation |
| description |
Chuan Qin,1,* Yongning Li,2,* Kewei Wang1 1Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences & Comparative Medical Center, Peking Union Medical College, Beijing, 100021, People’s Republic of China; 2Department of International Medical Service & Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People’s Republic of China*These authors contributed equally to this workCorrespondence: Kewei Wang 5 Panjiayuan Nanli St., Beijing, 100021, People’s Republic of ChinaTel +010-67779915Email kkww02052015@hotmail.comAbstract: The transplantation of bone marrow-derived mesenchymal stem cells (BMMSCs) alleviates neuropathology and improves cognitive deficits in animal models with Alzheimer’s disease. However, the underlying mechanisms remain to be determined. Available data demonstrate transplanted BMMSCs can inhibit neuroinflammation, which may be related to microglial M1/M2 polarization and is regulated by the secretion of autocrine and paracrine cytokines. BMMSCs also mitigate Aβ plaques and Tau tangles in the brain, which may be associated with the recruitment of peripheral blood monocytes and the subsequent comprehensive effects. The therapeutic effects of stem cells involve potential mechanisms such as immunomodulation, apoptosis, and proliferation. BMMSC-mediated functional reconstruction through dynamic remodeling develops a novel balance. Herein, present review recapitulates the molecular basis of BMMSC-assisted biological processes and summarizes the possible mechanisms related to the interaction between BMMSCs and microglia. The transplanted BMMSCs can suppress neuroinflammation that plays a key role in the pathogenesis of Alzheimer’s disease.Keywords: Alzheimer’s disease, bone marrow-derived mesenchymal stem cells, microglia, immunomodulation, apoptosis |
| format |
article |
| author |
Qin C Li Y Wang K |
| author_facet |
Qin C Li Y Wang K |
| author_sort |
Qin C |
| title |
Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation |
| title_short |
Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation |
| title_full |
Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation |
| title_fullStr |
Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation |
| title_full_unstemmed |
Functional Mechanism of Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Animal Models with Alzheimer’s Disease: Inhibition of Neuroinflammation |
| title_sort |
functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with alzheimer’s disease: inhibition of neuroinflammation |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/5fb525e1262441c984af6b4faf1ed856 |
| work_keys_str_mv |
AT qinc functionalmechanismofbonemarrowderivedmesenchymalstemcellsinthetreatmentofanimalmodelswithalzheimerrsquosdiseaseinhibitionofneuroinflammation AT liy functionalmechanismofbonemarrowderivedmesenchymalstemcellsinthetreatmentofanimalmodelswithalzheimerrsquosdiseaseinhibitionofneuroinflammation AT wangk functionalmechanismofbonemarrowderivedmesenchymalstemcellsinthetreatmentofanimalmodelswithalzheimerrsquosdiseaseinhibitionofneuroinflammation |
| _version_ |
1718377562848100352 |